Cart
sales@molnova.com
Dehydroabiethylamine
CAS No. 1446-61-3
Dehydroabiethylamine( Leelamine | Leelamine free base | NSC-2955 | NSC 2955 | NSC2955 )
Catalog No. M27157 CAS No. 1446-61-3
Dehydroabiethylamine is an inducer of hepatic CYP2B activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 31 | In Stock |
|
Biological Information
-
Product NameDehydroabiethylamine
-
NoteResearch use only, not for human use.
-
Brief DescriptionDehydroabiethylamine is an inducer of hepatic CYP2B activity.
-
DescriptionDehydroabiethylamine is an inducer of hepatic CYP2B activity. Dehydroabiethylamine inhibits pyruvate dehydrogenase kinases (PDKs) and intracellular cholesterol transport with anti-tumor activity.
-
In Vitro——
-
In Vivo——
-
SynonymsLeelamine | Leelamine free base | NSC-2955 | NSC 2955 | NSC2955
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
RecptorNF-κB
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1446-61-3
-
Formula Weight285.475
-
Molecular FormulaC20H31N
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (350.30 mM)
-
SMILESCC(C)c1ccc2c(CC[C@H]3[C@](C)(CN)CCC[C@]23C)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Okolotowicz KJ, et al. Selective benzimidazole inhibitors of the antigen receptor-mediated NF-kappaB activationpathway. Bioorg Med Chem. 2010 Mar 1;18(5):1918-24.
molnova catalog
related products
-
Furafylline
Furafylline is a selective inhibitor of human cytochrome P450 (CYP)1A2 (IC50 : 0.07 μM)
-
EN3356
EN3356 is an orally available and selective inhibitor of steroidal 17-alpha-hydroxylase/C17,20 cleavage enzyme (CYP17A1 or CYP17), a non-steroidal cleavage enzyme-selective compound with potential anti-androgenic and anti-tumor activity.
-
Cholesterol 24-hydro...
Cholesterol 24-hydroxylase-IN-1 is an orally active, selective, and potent inhibitor of cholesterol 24-hydroxylase (CH24H or CYP46A1) that crosses the blood-brain barrier.
